Chromaceutical Advanced Technologies Inc is categorized under Testing Laboratories in Hopkinton, MA and active since 2000.
Chromaceutical Advanced Technologies Inc was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Testing Laboratories business, which does work in the B2B market, and is classified as a Testing Laboratories, under code number 541380 by the NAICS.
If you are seeking more information, feel free to contact Robert Mateer at the company’s single location by writing to 63 South St # 130, Hopkinton, Massachusetts MA 01748 or by phoning (508) 497-2400. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Chromaceutical Advanced Technologies Inc |
| Contact Person: | Robert Mateer |
| Address: | 63 South St # 130, Hopkinton, Massachusetts 01748 |
| Phone Number: | (508) 497-2400 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Testing Laboratories |
| SIC Code: | 8734 |
| NAICS Code: | 541380 |
| Share This Business: |
Chromaceutical Advanced Technologies Inc was started in 2000 to provide professional Testing Laboratories under the SIC code 8734 and NAICS code 541380. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Robert Mateer for inquiries that concern Chromaceutical Advanced Technologies Inc by calling the company number (508) 497-2400, as your correspondence is most welcome. Additionally, the physical location of the single location of Chromaceutical Advanced Technologies Inc can be found at the coordinates as well as the street address 63 South St # 130 in Hopkinton, Massachusetts 01748.
For its online presence, you may visit Chromaceutical Advanced Technologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.